IBDEI0UT ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15198,0)
 ;;=461.9^^89^903^60
 ;;^UTILITY(U,$J,358.3,15198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15198,1,4,0)
 ;;=4^461.9
 ;;^UTILITY(U,$J,358.3,15198,1,5,0)
 ;;=5^Sinusitis, Acute
 ;;^UTILITY(U,$J,358.3,15198,2)
 ;;=^259080
 ;;^UTILITY(U,$J,358.3,15199,0)
 ;;=473.9^^89^903^59
 ;;^UTILITY(U,$J,358.3,15199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15199,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,15199,1,5,0)
 ;;=5^Sinusitis Chronic
 ;;^UTILITY(U,$J,358.3,15199,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,15200,0)
 ;;=091.0^^89^903^65
 ;;^UTILITY(U,$J,358.3,15200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15200,1,4,0)
 ;;=4^091.0
 ;;^UTILITY(U,$J,358.3,15200,1,5,0)
 ;;=5^Syphilis,Primary Genital
 ;;^UTILITY(U,$J,358.3,15200,2)
 ;;=^50581
 ;;^UTILITY(U,$J,358.3,15201,0)
 ;;=097.0^^89^903^63
 ;;^UTILITY(U,$J,358.3,15201,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15201,1,4,0)
 ;;=4^097.0
 ;;^UTILITY(U,$J,358.3,15201,1,5,0)
 ;;=5^Syphilis,Latent
 ;;^UTILITY(U,$J,358.3,15201,2)
 ;;=^266781
 ;;^UTILITY(U,$J,358.3,15202,0)
 ;;=094.9^^89^903^64
 ;;^UTILITY(U,$J,358.3,15202,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15202,1,4,0)
 ;;=4^094.9
 ;;^UTILITY(U,$J,358.3,15202,1,5,0)
 ;;=5^Syphilis,Neurosyphilis
 ;;^UTILITY(U,$J,358.3,15202,2)
 ;;=^83026
 ;;^UTILITY(U,$J,358.3,15203,0)
 ;;=097.9^^89^903^62
 ;;^UTILITY(U,$J,358.3,15203,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15203,1,4,0)
 ;;=4^097.9
 ;;^UTILITY(U,$J,358.3,15203,1,5,0)
 ;;=5^Syphilis NOS
 ;;^UTILITY(U,$J,358.3,15203,2)
 ;;=^116808
 ;;^UTILITY(U,$J,358.3,15204,0)
 ;;=463.^^89^903^66
 ;;^UTILITY(U,$J,358.3,15204,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15204,1,4,0)
 ;;=4^463.
 ;;^UTILITY(U,$J,358.3,15204,1,5,0)
 ;;=5^Tonsillitis
 ;;^UTILITY(U,$J,358.3,15204,2)
 ;;=^2695
 ;;^UTILITY(U,$J,358.3,15205,0)
 ;;=130.9^^89^903^67
 ;;^UTILITY(U,$J,358.3,15205,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15205,1,4,0)
 ;;=4^130.9
 ;;^UTILITY(U,$J,358.3,15205,1,5,0)
 ;;=5^Toxoplasmosis NOS
 ;;^UTILITY(U,$J,358.3,15205,2)
 ;;=^120695
 ;;^UTILITY(U,$J,358.3,15206,0)
 ;;=011.90^^89^903^68
 ;;^UTILITY(U,$J,358.3,15206,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15206,1,4,0)
 ;;=4^011.90
 ;;^UTILITY(U,$J,358.3,15206,1,5,0)
 ;;=5^Tuberculosis
 ;;^UTILITY(U,$J,358.3,15206,2)
 ;;=^122756
 ;;^UTILITY(U,$J,358.3,15207,0)
 ;;=614.2^^89^903^69
 ;;^UTILITY(U,$J,358.3,15207,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15207,1,4,0)
 ;;=4^614.2
 ;;^UTILITY(U,$J,358.3,15207,1,5,0)
 ;;=5^Tubo-Ovarian Abcess
 ;;^UTILITY(U,$J,358.3,15207,2)
 ;;=^107806
 ;;^UTILITY(U,$J,358.3,15208,0)
 ;;=788.7^^89^903^72
 ;;^UTILITY(U,$J,358.3,15208,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15208,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,15208,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,15208,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,15209,0)
 ;;=131.02^^89^903^73
 ;;^UTILITY(U,$J,358.3,15209,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15209,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,15209,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,15209,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,15210,0)
 ;;=597.80^^89^903^74
 ;;^UTILITY(U,$J,358.3,15210,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15210,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,15210,1,5,0)
 ;;=5^Urethritis, Unsp
 ;;^UTILITY(U,$J,358.3,15210,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,15211,0)
 ;;=079.99^^89^903^78
 ;;^UTILITY(U,$J,358.3,15211,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15211,1,4,0)
 ;;=4^079.99
 ;;^UTILITY(U,$J,358.3,15211,1,5,0)
 ;;=5^Viral Syndrome
 ;;^UTILITY(U,$J,358.3,15211,2)
 ;;=^295798
